NO993901D0 - Bicyclic amino acids - Google Patents
Bicyclic amino acidsInfo
- Publication number
- NO993901D0 NO993901D0 NO993901A NO993901A NO993901D0 NO 993901 D0 NO993901 D0 NO 993901D0 NO 993901 A NO993901 A NO 993901A NO 993901 A NO993901 A NO 993901A NO 993901 D0 NO993901 D0 NO 993901D0
- Authority
- NO
- Norway
- Prior art keywords
- amino acids
- bicyclic amino
- bicyclic
- acids
- amino
- Prior art date
Links
- -1 Bicyclic amino acids Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19705450A DE19705450A1 (en) | 1997-02-13 | 1997-02-13 | Bicyclic aromatic amino acids |
| PCT/EP1998/000636 WO1998035949A1 (en) | 1997-02-13 | 1998-02-06 | Bicyclic amino acids |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO993901D0 true NO993901D0 (en) | 1999-08-12 |
| NO993901L NO993901L (en) | 1999-10-12 |
| NO313289B1 NO313289B1 (en) | 2002-09-09 |
Family
ID=7820093
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19993901A NO313289B1 (en) | 1997-02-13 | 1999-08-12 | Bisyclic amino acids, process for their preparation, pharmaceutical composition, process for their preparation, use of the compounds for the preparation of a drug use as <alfa> v-integrin inhibitor |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP0964856B1 (en) |
| JP (1) | JP4327257B2 (en) |
| KR (1) | KR20000071030A (en) |
| CN (1) | CN1085205C (en) |
| AR (1) | AR010894A1 (en) |
| AT (1) | ATE225776T1 (en) |
| AU (1) | AU735313B2 (en) |
| BR (1) | BR9807345A (en) |
| CA (1) | CA2280727C (en) |
| CY (1) | CY2341B1 (en) |
| CZ (1) | CZ297366B6 (en) |
| DE (2) | DE19705450A1 (en) |
| DK (1) | DK0964856T3 (en) |
| ES (1) | ES2183332T3 (en) |
| HU (1) | HUP0001138A3 (en) |
| ID (1) | ID22533A (en) |
| NO (1) | NO313289B1 (en) |
| PL (1) | PL335101A1 (en) |
| PT (1) | PT964856E (en) |
| RU (1) | RU2187506C2 (en) |
| SI (1) | SI0964856T1 (en) |
| SK (1) | SK284646B6 (en) |
| TR (1) | TR199901962T2 (en) |
| WO (1) | WO1998035949A1 (en) |
| ZA (1) | ZA981178B (en) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040063790A1 (en) * | 1996-05-31 | 2004-04-01 | The Scripps Research Institute | Methods for inhibition of angiogenesis |
| ATE542797T1 (en) | 1998-04-09 | 2012-02-15 | Meiji Seika Pharma Co Ltd | AMINOPIPERIDINE DERIVATIVES AS INTEGRIN ALPHA V BETA 3 ANTAGONISTS |
| PL351279A1 (en) | 1999-04-13 | 2003-04-07 | Abbott Gmbh & Co Kg | Integrin receptor ligands |
| AU6316900A (en) | 1999-08-05 | 2001-03-05 | Meiji Seika Kaisha Ltd. | Omega-amino-alpha-hydroxycarboxylic acid derivatives having integrin alphavbeta3antagonism |
| EP1244616A1 (en) * | 1999-12-24 | 2002-10-02 | SmithKline Beecham plc | (hetero)bicyclylmethanesulfonylamino-substituted hydroxamic acid derivatives |
| DE60101351T2 (en) * | 2000-01-25 | 2004-10-07 | Kaneka Corp | METHOD FOR PRODUCING OPTICALLY ACTIVE, N-SUBSTITUTED AZETIDINE-2-CARBONIC ACIDS |
| CN100571772C (en) * | 2000-11-01 | 2009-12-23 | 默克专利有限公司 | Use of antagonists of the integrin receptors α v β 3 and/or α v β 5 for the production of medicaments for the treatment of eye diseases |
| ATE415163T1 (en) * | 2000-11-01 | 2008-12-15 | Merck Patent Gmbh | METHODS AND COMPOSITIONS FOR TREATING EYE DISEASES |
| EP1404860B8 (en) | 2001-05-30 | 2013-12-25 | The Scripps Research Institute | Delivery system for nucleic acids |
| HUP0401605A3 (en) | 2001-08-01 | 2012-09-28 | Merck Patent Gmbh | Integrin inhibitors for the treatment of eye diseases |
| RU2004127577A (en) * | 2002-02-14 | 2005-05-27 | Мерк Патент ГмбХ (DE) | METHODS AND COMPOSITIONS FOR TREATING EYE DISEASES |
| FR2847254B1 (en) * | 2002-11-19 | 2005-01-28 | Aventis Pharma Sa | NOVEL VITRONECTIN RECEPTOR ANTAGONIST DERIVATIVES, PROCESS FOR PREPARING THEM, THEIR APPLICATION AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS REFLECTING THEM |
| DE10305784A1 (en) * | 2003-02-12 | 2004-08-26 | Merck Patent Gmbh | 3-Oxo-3,4-dihydro-2H-benz-(1,4)-oxazin-6-yl)-propionic acid derivative preparation, for use as integrin inhibitors with e.g. antitumor action, by multi-stage process giving diastereomerically pure product |
| DE10337863A1 (en) | 2003-08-18 | 2005-03-17 | Merck Patent Gmbh | Use of chromene-4-one derivatives |
| EP2484364B1 (en) * | 2004-06-04 | 2014-02-19 | The Scripps Research Institute | Compositions for treatment of neovascular diseases |
| UA87854C2 (en) | 2004-06-07 | 2009-08-25 | Мерк Энд Ко., Инк. | N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators |
| PL2380881T3 (en) * | 2008-12-26 | 2017-07-31 | Sumitomo Dainippon Pharma Co., Ltd. | Novel bicyclic heterocyclic compound |
| WO2011024987A1 (en) * | 2009-08-31 | 2011-03-03 | 塩野義製薬株式会社 | Aromatic fused heterocyclic derivative and pharmaceutical composition containing same |
| AR090259A1 (en) | 2012-03-06 | 2014-10-29 | Boehringer Ingelheim Int | BENZODIOXAN INHIBITORS OF LEUCOTRENE PRODUCTION FOR COMBINATION THERAPY |
| TW201416354A (en) | 2012-07-17 | 2014-05-01 | Boehringer Ingelheim Int | Inhibitors of leukotriene production |
| EP3022194B1 (en) | 2013-07-15 | 2017-05-17 | Boehringer Ingelheim International GmbH | Inhibitors of leukotriene production |
| WO2015009609A1 (en) | 2013-07-15 | 2015-01-22 | Boehringer Ingelheim International Gmbh | Inhibitors of leukotriene production |
| MX2016015467A (en) | 2014-05-30 | 2017-03-23 | Pfizer | Carbonitrile derivatives as selective androgen receptor modulators. |
| WO2023275715A1 (en) | 2021-06-30 | 2023-01-05 | Pfizer Inc. | Metabolites of selective androgen receptor modulators |
| CA3221177A1 (en) | 2021-11-01 | 2023-05-04 | Meghan Kerrisk Campbell | Benzodioxane modulators of leukotriene a4 hydrolase (lta4h) for prevention and treatment of aging-associated diseases |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3151690A1 (en) * | 1981-12-29 | 1983-07-07 | Hoechst Ag, 6230 Frankfurt | Novel derivatives of bicyclic amino acids, process for their preparation, compositions containing them and their use, and also novel bicyclic amino acids as intermediates and process for their preparation |
| FR2674854B1 (en) * | 1991-04-04 | 1995-03-03 | Bouchara | NEW QUINOLONES THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS THEREOF. |
| US5648368A (en) * | 1992-12-01 | 1997-07-15 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
| DE69528829T2 (en) * | 1994-05-27 | 2003-08-07 | Merck & Co., Inc. | PREPARATIONS FOR INHIBITING BONE RESORPTION BROUGHT BY OSTEOCLASTIC |
| DE19548709A1 (en) * | 1995-12-23 | 1997-07-03 | Merck Patent Gmbh | Tyrosine derivatives |
| DE19654483A1 (en) * | 1996-06-28 | 1998-01-02 | Merck Patent Gmbh | Phenylalanine derivatives |
| EP0907637A1 (en) * | 1996-06-28 | 1999-04-14 | MERCK PATENT GmbH | Phenylalamine derivatives as integrin inhibitors |
-
1997
- 1997-02-13 DE DE19705450A patent/DE19705450A1/en not_active Withdrawn
-
1998
- 1998-02-06 BR BR9807345A patent/BR9807345A/en not_active Application Discontinuation
- 1998-02-06 TR TR1999/01962T patent/TR199901962T2/en unknown
- 1998-02-06 AT AT98908063T patent/ATE225776T1/en not_active IP Right Cessation
- 1998-02-06 JP JP53530398A patent/JP4327257B2/en not_active Expired - Fee Related
- 1998-02-06 RU RU99119223/04A patent/RU2187506C2/en not_active IP Right Cessation
- 1998-02-06 ES ES98908063T patent/ES2183332T3/en not_active Expired - Lifetime
- 1998-02-06 EP EP98908063A patent/EP0964856B1/en not_active Expired - Lifetime
- 1998-02-06 HU HU0001138A patent/HUP0001138A3/en unknown
- 1998-02-06 CA CA002280727A patent/CA2280727C/en not_active Expired - Fee Related
- 1998-02-06 SI SI9830304T patent/SI0964856T1/en unknown
- 1998-02-06 ID IDW990812A patent/ID22533A/en unknown
- 1998-02-06 KR KR1019997007297A patent/KR20000071030A/en not_active Ceased
- 1998-02-06 SK SK1071-99A patent/SK284646B6/en unknown
- 1998-02-06 AU AU66206/98A patent/AU735313B2/en not_active Ceased
- 1998-02-06 DK DK98908063T patent/DK0964856T3/en active
- 1998-02-06 CZ CZ0287599A patent/CZ297366B6/en not_active IP Right Cessation
- 1998-02-06 PL PL98335101A patent/PL335101A1/en unknown
- 1998-02-06 DE DE59805895T patent/DE59805895D1/en not_active Expired - Lifetime
- 1998-02-06 WO PCT/EP1998/000636 patent/WO1998035949A1/en not_active Ceased
- 1998-02-06 PT PT98908063T patent/PT964856E/en unknown
- 1998-02-06 CN CN98803959A patent/CN1085205C/en not_active Expired - Fee Related
- 1998-02-12 ZA ZA981178A patent/ZA981178B/en unknown
- 1998-02-13 AR ARP980100654A patent/AR010894A1/en not_active Application Discontinuation
-
1999
- 1999-08-12 NO NO19993901A patent/NO313289B1/en not_active IP Right Cessation
-
2003
- 2003-03-17 CY CY0300028A patent/CY2341B1/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO993901L (en) | Bicyclic amino acids | |
| DK0877018T3 (en) | Sulfonylaminocarboxylic acids | |
| NO20002990L (en) | New surface protein | |
| DE69839603D1 (en) | ORNAMENTAL PROTEINS | |
| FI953837A0 (en) | Synthetic activating amino acids | |
| IS5375A (en) | KAY-Innovative Immune Protein | |
| NO2010013I2 (en) | Recombinant FSH-CTP | |
| DE69832623D1 (en) | MICRO-MADE CIRCLES | |
| NO985680D0 (en) | peptide | |
| DE69815952D1 (en) | polisher | |
| DE69830139D1 (en) | ULTRASONIC LOCKENWICKELGERÄT | |
| NO994548D0 (en) | Railing | |
| NO983849D0 (en) | peptide | |
| DE69816146D1 (en) | polisher | |
| BR9609671A (en) | Amino uracilas substituted | |
| DE69838161D1 (en) | polisher | |
| TR199701666A3 (en) | Proteins | |
| DK0862850T3 (en) | combine | |
| DE69808762D1 (en) | CONNECTION PART | |
| DE69834398D1 (en) | PENDANT | |
| DE59806788D1 (en) | Lights Set | |
| DK1017798T3 (en) | lunasin peptides | |
| NO20000976D0 (en) | peptides | |
| ATA188297A (en) | FITTING | |
| ATE204219T1 (en) | BOND HEAD |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |